Cargando…
Are We Ready for NGS HIV Drug Resistance Testing? The Second “Winnipeg Consensus” Symposium
HIV drug resistance is a major global challenge to successful and sustainable antiretroviral therapy. Next-generation sequencing (NGS)-based HIV drug resistance (HIVDR) assays enable more sensitive and quantitative detection of drug-resistance-associated mutations (DRMs) and outperform Sanger sequen...
Autores principales: | Ji, Hezhao, Sandstrom, Paul, Paredes, Roger, Harrigan, P. Richard, Brumme, Chanson J., Avila Rios, Santiago, Noguera-Julian, Marc, Parkin, Neil, Kantor, Rami |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7354487/ https://www.ncbi.nlm.nih.gov/pubmed/32471096 http://dx.doi.org/10.3390/v12060586 |
Ejemplares similares
-
Bioinformatic data processing pipelines in support of next‐generation sequencing‐based HIV drug resistance testing: the Winnipeg Consensus
por: Ji, Hezhao, et al.
Publicado: (2018) -
Performance comparison of next generation sequencing analysis pipelines for HIV-1 drug resistance testing
por: Lee, Emma R., et al.
Publicado: (2020) -
Next-Generation Sequencing for HIV Drug Resistance Testing: Laboratory, Clinical, and Implementation Considerations
por: Ávila-Ríos, Santiago, et al.
Publicado: (2020) -
Multi-Laboratory Comparison of Next-Generation to Sanger-Based Sequencing for HIV-1 Drug Resistance Genotyping
por: Parkin, Neil T., et al.
Publicado: (2020) -
External Quality Assessment Program for Next-Generation Sequencing-Based HIV Drug Resistance Testing: Logistical Considerations
por: Ji, Hezhao, et al.
Publicado: (2020)